The stream · Daily digest
The stream: Sunday, October 18, 2026
1 brief, grouped by desk. Each is two sentences from one primary source, linked to it.
Machine-summarized from primary sources; not independently reported. How we use automation
Clinical trials · 1
-
AbbVie announces data to be presented at 2026 ESMO Congress
AbbVie today announced that new and updated data from its broad solid tumor portfolio will be presented at the 2026 European Society for Medical Oncology Congress in Madrid, Spain. The presentations cover investigational assets such as Temab-A, ABBV-706, ABBV-969, ABBV-1480, alveltamig, EmrelisTM and Elahere.
Source: Company press release (PR Newswire), October 18, 2026